丰山集团(603810) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was ¥395,516,977.68, representing a decrease of 10.40% compared to the same period last year[4]. - The net profit attributable to shareholders was ¥10,385,354.62, down 65.99% year-on-year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥5,053,350.10, a decline of 80.98% compared to the previous year[4]. - The basic earnings per share for the period was ¥0.06, reflecting a decrease of 68.42% year-on-year[4]. - Total operating revenue for Q1 2023 was ¥395,516,977.68, a decrease of 10.4% compared to ¥441,406,976.76 in Q1 2022[18]. - Net profit for Q1 2023 was ¥10,106,438.02, a decline of 66.9% from ¥30,534,902.58 in Q1 2022[19]. - Earnings per share for Q1 2023 were ¥0.06, compared to ¥0.19 in Q1 2022[20]. Assets and Liabilities - Total assets at the end of the reporting period were ¥2,734,177,151.27, an increase of 2.51% from the end of the previous year[5]. - Total assets increased to ¥2,734,177,151.27 in Q1 2023 from ¥2,667,197,386.94 in Q1 2022, reflecting a growth of 2.5%[16]. - Total liabilities rose to ¥1,104,516,111.41 in Q1 2023, up from ¥1,067,938,797.83 in Q1 2022, indicating an increase of 3.4%[16]. - The total assets of the company as of January 1, 2023, were 2,669,022,709.13 RMB, reflecting an increase from 2,667,197,386.94 RMB at the end of 2022[27]. - The company's total liabilities remained stable at 622,194,355.82 RMB for current liabilities as of January 1, 2023[28]. Cash Flow - The cash flow from operating activities was negative at -¥34,337,868.16, indicating a significant cash outflow[4]. - In Q1 2023, the company reported a net cash flow from operating activities of -34,337,868.16 RMB, an improvement from -117,559,973.13 RMB in Q1 2022[23]. - Total cash inflow from investment activities was 716,177,893.67 RMB, significantly higher than 198,248,341.42 RMB in the same period last year, resulting in a net cash flow from investment activities of 142,059,333.18 RMB[24]. - The company experienced a net increase in cash and cash equivalents of 102,272,809.30 RMB in Q1 2023, contrasting with a decrease of -95,472,615.50 RMB in Q1 2022[24]. Equity and Shareholder Information - The equity attributable to shareholders increased by 1.92% to ¥1,630,134,439.70 compared to the end of the previous year[5]. - The top shareholder, Yin Fengshan, holds 41.72% of the shares, indicating a strong control over the company[10]. - Total equity attributable to shareholders reached ¥1,599.45 million, reflecting a minor decrease of ¥70.49 thousand compared to the last report[29]. - The total equity, including minority interests, was reported at ¥1,599.26 million, a decrease of ¥70.49 thousand[29]. Operational Changes - The company reported a decrease in trading financial assets, which fell to CNY 100,464,126.73 from CNY 260,440,869.56, a decline of about 61.4%[14]. - The company experienced a 53.01% increase in accounts receivable, attributed to sales payments still within the credit period[7]. - The company’s profit margin was impacted by a decline in pesticide product prices and overall market conditions, leading to a 54.25% decrease in total profit[8]. - The company has announced several significant announcements regarding stock repurchase and fundraising projects during the reporting period[11]. - The company is actively engaging in market expansion and new product development as part of its strategic initiatives[11]. Research and Development - The company reported a decrease in research and development expenses to ¥8,469,002.33 in Q1 2023 from ¥12,316,781.49 in Q1 2022, a reduction of 31.5%[19]. Accounting Standards - The company has adopted new accounting standards effective January 1, 2023, which may impact financial reporting[25].